Company / Assets per Share
MoonLake Immunotherapeutics Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.58
FY2025
5-year range
$1.23 / $10.72
FY2021-FY2025
Trend
-13.4%
vs FY2024
Sector context
#131 of 210
Health Care
What the data says
At $6.58, MoonLake Immunotherapeutics's assets per share ranks #131 of 210 in the Health Care sector. Declined from $10.72 to $6.58 over the past 2 years.
Based on SEC 10-K filings.
6.58 in FY2025 with a 5-year CAGR of -18.9%.
Declined from $10.72 to $6.58 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +36.0%
- 5-Year CAGR
- -18.9%
- 10-Year CAGR
- -
Sector benchmark
#131 of 210 in Health CareTop 62% of 210This company $6.58 Sector average $353.15
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 13.4% year-over-year.
- Ranks #131 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.58 | -13.4% |
| FY2024 | $7.60 | -29.1% |
| FY2023 | $10.72 | +309.6% |
| FY2022 | $2.62 | +111.9% |
| FY2021 | $1.23 | -93.4% |
| FY2020 | $18.72 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026